XML 33 R20.htm IDEA: XBRL DOCUMENT
v3.21.1

Stock Options and Restricted Stock Units | 12 Months Ended
--- | ---
Dec. 31, 2020
Share-based Payment Arrangement [Abstract] |
Stock Options and Restricted Stock Units | On June 21, 2004, our shareholders approved the adoption of the 2004 Employee Stock Option Plan (the “2004 Employee Stock Option Plan”) that provided for incentive stock options and nonqualified stock options to be granted to key employee and certain directors. Each option vested on either January 1, 2004 or immediately upon issuance thereafter. The exercise price of each option issued pursuant to the 2004 Plan is equal to the market value of our Common Stock on the date of grant, as determined by the closing bid price for our Common Stock on the Exchange on the date of grant or, if no trading occurred on the date of grant, on the last day prior to the date of grant on which our securities were listed and traded on the Exchange. Of the options issued under the 2004 Employee Stock Option Plan, 15,000 remain outstanding. Options issued pursuant to the 2004 Employee Stock Option Plan have no expiration date. The Company previously determined there will be no additional grants under the 2004 Employee Stock Option Plan. On December 7, 2016, our shareholders approved the adoption of the 2016 Equity Incentive Plan (the “2016 Plan”), which reserved 1,100,000 shares for issuance pursuant to awards issued thereunder. As of December 31, 2020, no awards had been made under the 2016 Plan. The following table summarizes the activity in common shares subject to options and warrants:
|  | Years Ended December 31, |
|  | 2020 |  |  | 2019 |
|  | Shares |  |  | Weighted average exercise price |  |  | Shares |  |  | Weighted average exercise price |
Outstanding at beginning or year |  |  | 15,000 |  |  | $ | 2.17 |  |  |  | 15,000 |  |  | $ | 2.17 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at end of year |  |  | 15,000 |  |  | $ | 2.17 |  |  |  | 15,000 |  |  | $ | 2.17 |
Options exercisable at end of year |  |  | 15,000 |  |  | $ | 2.17 |  |  |  | 15,000 |  |  | $ | 2.17 |
The 15,000 options exercisable at the end of the year are potential dilutive shares. Information about stock options outstanding at December 31, 2020 is summarized as follows:
|  |  |  | Options Outstanding and Exercisable |
| Exercise price |  |  | Number outstanding |  |  | Weighted average remaining contractual life (Years) |  |  |  |  |  | Weighted average exercise price |  |  | Aggregate intrinsic value |
| $ | 2.13 |  |  |  | 10,000 |  |  |  | NA |  |  |  | (1 | ) |  | $ | 2.13 |  |  | $ | 32,450 |
| $ | 2.25 |  |  |  | 5,000 |  |  |  | NA |  |  |  | (1 | ) |  | $ | 2.25 |  |  | $ | 15,600 |
|  |  |  |  |  | 15,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 48,050 |
(1) | Options currently issued pursuant to the Company’s 2004 Employee Stock Option Plans have no expiration date.
The aggregate intrinsic values in the above table were based on the closing price of our Common Stock of $5.37 as of December 31, 2020. A summary of the status of our non-vested RSU grants issued under our 2006 Plan is presented below:
|  | Year Ended December 31, |
|  | 2020 |  |  | 2019 |
|  | Shares |  |  | Weighted average exercise price |  |  | Shares |  |  | Weighted average exercise price |
Nonvested at beginning or year |  |  | 250 |  |  | $ | 1.30 |  |  |  | 250 |  |  | $ | 1.30 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | 250 |  |  |  | 1.30 |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at end of year |  |  | - |  |  | $ | - |  |  |  | 250 |  |  | $ | 1.30 |
As a result of the expiration of the 2006 Plan, as of December 31, 2019, no further shares could be issued under the 2006 Plan. As of January 1, 2020, the remaining 250 RSU grants have vested and were exercised during Fiscal 2020. A total of 1,100,000 shares remain available for future grants pursuant to the 2016 Plan. During Fiscal 2020 we recognized $325 of stock-based compensation expense compared to $0 in Fiscal 2019.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration